If you have diabetes, your doctor might suggest Basaglar (insulin glargine) as a treatment option for you. It’s a prescription drug used to treat: type 1 diabetes in adults and children ages 6 years ...
Basaglar (insulin glargine) is a brand-name drug that’s used to help manage blood sugar levels in certain people. The drug comes as a liquid solution that’s injected under your skin. It’s usually ...
The FINANCIAL — Eli Lilly and Company and Boehringer Ingelheim Pharmaceuticals, Inc. announced on December 15 that BASAGLAR (insulin glargine injection 100 units/mL) is available by prescription in ...
Eli Lilly and Company and Boehringer Ingelheim Pharmaceuticals, Inc. announced that Basaglar (insulin glargine injection 100 units/mL) is available by prescription in the US Basaglar is a follow-on ...
The U.S. Food and Drug Administration today approved Basaglar (insulin glargine injection), a long-acting human insulin analog to improve glycemic control in adult and pediatric patients with type 1 ...
INDIANAPOLIS and RIDGEFIELD, Conn., Aug. 18, 2014 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) today granted tentative approval for Basaglar™ (insulin glargine injection), which is ...
Medicare Part D may cover Basaglar, a long-acting insulin, and under the Inflation Reduction Act, the cost should not exceed $35 per month. The availability of Basaglar under Medicare Part D depends ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback